Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2017
False Claims Act settlement
The defendants agreed to pay $75 million to resolve the federal lawsuit. The settlement resolved the allegations without an adjudicated finding that every claim at issue was false.
2013
False Claims Act allegations involving Medicare crisis-care billing
The U.S. Department of Justice alleged that Chemed and VITAS-related entities submitted or caused the submission of false Medicare claims for crisis-care services that were unnecessary, not provided, or inconsistent with Medicare requirements.